Related Experiment Video
Updated: Jul 28, 2026
10:04
Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Naltrexone modulation of nicotinic acetylcholine receptor activity
A C Le Dain1, B W Madsen, R O Edeson
1Department of Pharmacology, University of Western Australia.
The Journal of Pharmacology and Experimental Therapeutics
|August 1, 1991
Summary
Naltrexone (NTX) can enhance nicotinic acetylcholine receptor (nAChR) activity by increasing acetylcholine (ACh) binding cooperativity. This study reveals NTX
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Nicotinic acetylcholine receptors (nAChRs) are crucial for neurotransmission.
- Naltrexone (NTX) exhibits complex modulatory effects on nAChR activity, including excitation.
- Understanding NTX's excitatory mechanisms is key to its therapeutic potential.
Purpose of the Study:
- To investigate the mechanisms underlying the excitatory effects of naltrexone on nicotinic acetylcholine receptors.
- To elucidate how naltrexone modulates the binding and gating kinetics of nAChRs.
Main Methods:
- Single-channel recordings from cultured embryonic chick skeletal muscle myotubes.
- Cell-attached patch-clamp electrophysiology at 10°C.
- Analysis of open and closed time distributions and autocorrelation data.
- Kinetic modeling using Markov processes to determine channel states and transition rates.
Main Results:
- Naltrexone (NTX) enhances nicotinic acetylcholine receptor (nAChR) activity.
- Increased cooperativity of acetylcholine (ACh) binding is the primary mechanism for NTX-induced enhancement.
- A superior six-state kinetic model revealed NTX's allosteric coupling to activation and gating processes.
Conclusions:
- Low micromolar concentrations of naltrexone enhance chick nAChR activity primarily through increased ACh binding cooperativity.
- Naltrexone's modulatory effects involve allosteric interactions with multiple activation and gating sites.
- These findings provide insights into the complex pharmacology of naltrexone at the nicotinic acetylcholine receptor.
More Related Videos
Related Concept Videos
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:26Neurochemical Transmission: Sites of Drug Action
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
01:15Cholinergic Receptors: Nicotinic
Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...